Article
MPM backs $53M round for a bold concept: Let patients make their own CAR-T in vivo
Rating:
0.0
Views:
75
Likes:
1
Library:
1
The onerous process of making a personalized CAR-T — one that involves extracting cells from patients, engineering and then injecting them back — is one of the defining features of the first generation of engineered cell therapies. It's partly why the treatments are so expensive; it's also an inspiration for
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value